4//SEC Filing
Actinium Pharmaceuticals, Inc. 4
Accession 0001213900-17-006531
$ATNMCIK 0001388320operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:56 PM ET
Size
4.6 KB
Accession
0001213900-17-006531
Insider Transaction Report
Form 4
Berger Mark Stanley
Chief Medical Officer
Transactions
- Purchase
Common stock
2017-06-15$1.11/sh+5,000$5,550→ 5,000 total
Documents
Issuer
Actinium Pharmaceuticals, Inc.
CIK 0001388320
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001388320
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:56 PM ET
- Size
- 4.6 KB